Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews-Reference-Cited by-同舟云学术

Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews

Published:2020-07-15 Issue:4 Volume:24 Page:357-370
ISSN:1365-1501
Container-title:International Journal of Psychiatry in Clinical Practice
language:en
Short-container-title:International Journal of Psychiatry in Clinical Practice

Author:

Ghaffari Darab Mohsen¹,Hedayati Arvin²,Khorasani Elahe³,Bayati Mohsen⁴,Keshavarz Khosro⁴^ORCID

Affiliation:

1. School of Management & Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran

2. Research Center for Psychiatry and Behavior Science, Shiraz University of Medical Sciences, Shiraz, Iran

3. Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

4. Health Human Resources Research Center, School of Management and Medical Informatics, Shiraz University of Medical Sciences, Shiraz, Iran

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/13651501.2020.1782433

Reference20 articles.

1. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or nonrandomised studies of healthcare interventions, or both. Retrieved 25 July 2018, from http://www.amstar.ca/docs/AMSTAR-2.pdf

2. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabrication of fMW@TiO2@MoS2-Sm2S3/GCE electrochemical nanosensor for simultaneous measurement of sertraline and buspirone neuroleptic drugs;Surfaces and Interfaces;2024-10

2. Hierarchical and Complex Pharmacotherapy Decision-Making;Clinical Reasoning and Decision-Making in Psychiatry;2024-03-31

3. Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial;BMC Psychiatry;2024-02-26

4. Establishment and Validation of a Transdermal Drug Delivery System for the Anti-Depressant Drug Citalopram Hydrobromide;Molecules;2024-02-07

5. Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial;Multiple Sclerosis Journal;2023-12-21